Fauci: ‘Full-Court Press’ to End HIV Epidemic in U.S.

NIAID chief outlines plan for treatment as prevention, PrEP in targeted areas

SEATTLE — The much-discussed plan to end the HIV epidemic in the U.S. through targeted treatment and prevention outreach is the first time an accelerated effort has been undertaken by multiple Health and Human Services agencies to tackle this problem, speakers said at a special session here.

In a talk at the opening plenary session of the Conference on Retroviruses and Opportunistic Infections, Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID), outlined the plan previewed by President Trump in his State of the Union address in February to reduce the number of new HIV infections in the U.S. by 75% in 5 years, and by 90% in 10 years.

“We have PEPFAR and the Global Fund, but we’ve been talking for 10 years about the feasibility of ending the epidemic [in the U.S.]. This is a full-court press,” Fauci told MedPage Today in a pre-conference interview.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search